by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

IDO Pharm Co., Ltd. Warning Letter Details

Warning Letter

IDO Pharm Co., Ltd.

IDO Pharm Co., Ltd., 41 Beonnyeong-ro, 15 beon-gil Danwon-gu Ansan-si Gyeonggi-do 15616 South Korea

Issue DateMay 04, 2026

FEI Number3017021001

Violations4

CountrySouth Korea

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC Finished Pharmaceuticals/Adulterated

IDO Pharm Co., Ltd. FDA Warning Letter, May 4, 2026